Smith Michael David

Senior VP, Development at KALV

Sold, on record
$459k
Dollars the filings state
Form 4 sales
2
Latest Jun 1, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • KALVKalVista Pharmaceuticals, Inc.Senior VP, Development

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale KALVUnusual
    Apr 28, 2021 2021

    Sold 10,014 shares at $25.76 ($258k)

    Smith Michael David, Senior VP, Development

    Sold 100% of holdings ($258k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale KALVUnusual
    Jun 1, 2021 +34 days

    Sold 7,500 shares at $26.83 ($201k)

    Smith Michael David, Senior VP, Development

    Sold 100% of holdings ($201k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Smith Michael David
Source
Jun 1, 2021Jun 3, 2021KALVSenior VP, DevelopmentForm 4 sale7,500$201k100.0%UnusualSEC
Apr 28, 2021Apr 30, 2021KALVSenior VP, DevelopmentForm 4 sale10,014$258k100.0%UnusualSEC